Skip to content

Charles River Laboratories CRL Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
Revvity logo
RevvityRVTY
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Quest Diagnostics logo
Quest DiagnosticsDGX

Segments

By segment

See full
DSA$10.36M-21.6%
RMS$3.04M-49.1%
Manufacturing$1.95M-95.8%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's amortization of capitalized software and acquired intangible assets?
Charles River Laboratories (CRL) reported amortization of capitalized software and acquired intangible assets of $15.35M in Q1 2026.
How has Charles River Laboratories's amortization of capitalized software and acquired intangible assets changed year-over-year?
Charles River Laboratories's amortization of capitalized software and acquired intangible assets decreased by 76.5% year-over-year, from $65.26M to $15.35M.
What is the long-term trend for Charles River Laboratories's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Charles River Laboratories's amortization of capitalized software and acquired intangible assets has grown at a 9.4% compound annual growth rate (CAGR), from $124.86M to $179.07M.